Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension. [electronic resource]
- The Journal of pharmacology and experimental therapeutics Mar 2006
- 1269-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0022-3565
10.1124/jpet.105.092783 doi
Adrenomedullin Animals Body Weight--drug effects Hydralazine--pharmacology Hydrochlorothiazide--pharmacology Hypertension--drug therapy Intracellular Signaling Peptides and Proteins--genetics Male Membrane Proteins--genetics Myocytes, Cardiac--metabolism Myosin Heavy Chains--genetics NG-Nitroarginine Methyl Ester--pharmacology Neuropeptides--genetics Nitric Oxide--deficiency Organ Size--drug effects Peptides--genetics RNA, Messenger--analysis Rats Rats, Sprague-Dawley Receptor Activity-Modifying Protein 1 Receptor Activity-Modifying Protein 2 Receptor Activity-Modifying Protein 3 Receptor Activity-Modifying Proteins Receptors, Adrenomedullin Receptors, Peptide--genetics Systole--drug effects